Defence Therapeutics Inc. (CSE:DTC)
Canada
· Delayed Price · Currency is CAD 0.600
-0.020 (-3.23%)
Mar 9, 2026, 3:59 PM EST
Defence Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Net Income | -4.33 | -3.52 | -13.19 | -6.76 | -7.34 | -2.86 | Upgrade
|
| Depreciation & Amortization | 0.06 | 0.07 | 0.09 | 0.01 | - | - | Upgrade
|
| Stock-Based Compensation | 0.76 | 0.79 | 5.84 | 0.3 | 0.37 | 0.61 | Upgrade
|
| Other Operating Activities | 0.22 | 0.24 | 0.4 | 0.16 | - | - | Upgrade
|
| Change in Accounts Receivable | -0.18 | -0.1 | 0.05 | -0.12 | 0.04 | - | Upgrade
|
| Change in Accounts Payable | -1.47 | -0.91 | 2.1 | -0.89 | 0.98 | 0.07 | Upgrade
|
| Change in Other Net Operating Assets | -0 | 0.03 | 0.43 | -0.35 | -0.1 | -0.11 | Upgrade
|
| Operating Cash Flow | -4.94 | -3.4 | -4.29 | -7.66 | -6.04 | -2.29 | Upgrade
|
| Capital Expenditures | -0.02 | - | -0.2 | -0.07 | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | -0.02 | 0 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.03 | 0 | -0.2 | -0.07 | - | - | Upgrade
|
| Short-Term Debt Issued | - | 0.02 | 0.05 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 2.36 | - | - | Upgrade
|
| Total Debt Issued | 2 | 0.02 | 0.05 | 2.36 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -0.07 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.12 | -0.06 | - | - | - | Upgrade
|
| Total Debt Repaid | -0.04 | -0.18 | -0.06 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 1.96 | -0.17 | -0.01 | 2.36 | - | - | Upgrade
|
| Issuance of Common Stock | 4.24 | 5.02 | 1.89 | 8.25 | 1.1 | 2.76 | Upgrade
|
| Other Financing Activities | -0.42 | -0.28 | -0.12 | -0.59 | - | 3.12 | Upgrade
|
| Financing Cash Flow | 5.79 | 4.57 | 1.76 | 10.01 | 1.1 | 5.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 0.82 | 1.18 | -2.74 | 2.29 | -4.95 | 3.59 | Upgrade
|
| Free Cash Flow | -4.95 | -3.4 | -4.49 | -7.72 | -6.04 | -2.29 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.07 | -0.10 | -0.20 | -0.17 | -0.09 | Upgrade
|
| Cash Interest Paid | 0.01 | 0 | 0.04 | 0.01 | - | - | Upgrade
|
| Levered Free Cash Flow | -3.58 | -2.31 | 0.09 | -5.34 | -3.25 | -1.2 | Upgrade
|
| Unlevered Free Cash Flow | -3.4 | -2.11 | 0.34 | -5.18 | -3.25 | -1.2 | Upgrade
|
| Change in Working Capital | -1.65 | -0.99 | 2.58 | -1.36 | 0.93 | -0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.